Disclosure Panels Details Page
Skin Cancers Excluding Melanoma Panel - Disclosures as of 09/10/2019
|
Panel Member
(Spouse/Domestic Partner/Dependent) |
Clinical Research Support/Data Safety Monitoring Board | Scientific Advisory Boards, Consultant, or Expert Witness | Promotional Advisory Boards, Consultant, or Speakers Bureau | Employment/ Governing Board, Patent, Equity, or Royalty | Has Attended |
|---|---|---|---|---|---|
| Sumaira Aasi MD | None | None | None | None | - |
| Murad Alam MD, MBA, MSCI | None | Pulse BioSciences | None | None | - |
| James Andersen MD | None | None | None | None | - |
| Marian Birkeland PhD | None | None | None | None | - |
| Rachel Blitzblau MD, PhD | None | None | None | None | - |
| Jeremy Bordeaux MD, MPH | None | None | None | None | ✔ |
| Glen Bowen MD | None | None | None | None | - |
| William Carson III MD | None | None | None | None | ✔ |
| Pei-Ling Chen MD, PhD | None | None | None | None | - |
| Carlo Contreras MD | None | Medical Review Institutes of America | None | None | ✔ |
| Mackenzie Daly MD | None | None | None | None | - |
| Gregory Daniels MD, PhD | Bristol Myers Squibb Iovance Merck & Co., Inc. Nektar Therapeutics |
sanofi-aventis U.S. | Regeneron Pharmaceuticals, Inc. sanofi-aventis U.S. |
None | - |
| Sarah DeVincenzo PharmD, BCPS | None | None | None | None | - |
| Dominick DiMaio MD | None | None | None | None | ✔ |
| Anita Engh PhD | None | None | None | None | ✔ |
| Jeffrey Farma MD | Delcath | None | None | None | - |
| Kristopher Fisher MD | None | None | None | None | - |
| Karthik Ghosh MD | None | American college of physicians- MKSAP 18 contributor | None | None | ✔ |
| Kristina Gregory MSN, RN | None | None | None | None | - |
| Roy Grekin MD | None | None | None | None | - |
| Lydia Hammond MBA | None | None | None | Merck & Co., Inc.|NeoGenomics Laboratories | ✔ |
| Evelyn Handel PharmD, BCOP, BCPS | None | None | None | None | - |
| Kelly Harms MD, PhD | Dynavax Technologies Corp and collaborator Merk Sharp & Dohme Corp | None | None | None | - |
| Alan Ho MD, PhD | Astellas Pharma US, Inc. AstraZeneca Pharmaceuticals LP Ayala Pharmaceuticals Bayer HealthCare Bristol Myers Squibb Celldex Therapeutics Eisai Inc. Genentech, Inc. Kura Oncology, Inc. Merck & Co., Inc. Novartis Pharmaceuticals Corporation Regeneron Pharmaceuticals, Inc. |
Ayala Pharmaceuticals CureVac Klus Pharma |
None | International Thyroid Oncology Group | - |
| Ann Karosas RPh, BCOP | None | None | None | None | - |
| Donald Lawrence MD | NA | NA | NA | NA | - |
| Karl Lewis MD | Array Bristol Myers Squibb Incyte Corporation Iovance Kartos Merck & Co., Inc. Nektar Therapeutics Neon Regeneron Pharmaceuticals, Inc. Roche Laboratories, Inc. |
Genentech, Inc. Merck & Co., Inc. Regeneron Pharmaceuticals, Inc. |
None | None | ✔ |
| Manisha Loss MD | None | None | None | None | - |
| John Nicholas Lukens MD | None | None | None | None | - |
| Kishwer Nehal MD | None | None | None | None | - |
| Paul Nghiem MD, PhD | Bristol Myers Squibb | EMD Serono Merck & Co., Inc. Pfizer Inc. sanofi-aventis U.S. |
None | None | ✔ |
| Sharon Park PharmD, BCOP | None | None | None | None | - |
| Donna Powell DHSc, CMD, RT(T) | None | None | None | None | - |
| Igor Puzanov MD, MSCI, FACP | None | Amgen Inc. | None | None | ✔ |
| Leslie Ray PharmD | None | None | None | None | - |
| Chrysalyne Schmults MD, MS | Castle Biosciences Genentech, Inc. Merck & Co., Inc. Novartis Pharmaceuticals Corporation Regeneron Pharmaceuticals, Inc. |
Castle Biosciences Regeneron Pharmaceuticals, Inc. sanofi-aventis U.S. |
None | None | ✔ |
| Aleksandar Sekulic MD, PhD | None | None | None | None | - |
| Ashok Shaha MD | None | None | None | None | ✔ |
| William Stebbins MD | None | None | None | None | - |
| Valencia Thomas MD | None | None | None | None | - |
| Erin Vidic | None | None | None | None | - |
| Amanda Visnick BSN, RN, OCN | None | None | None | None | - |
| Yaohui Gloria Xu MD, PhD | None | None | None | None | - |